Experts Scrutinize Huidagene’s Disclosures

Experts are scrutinizing disclosures from Huidagene, a biotech company, following a patient death. The scrutiny centers on Merck and Moderna's mRNA cancer vaccine, which is under review by a potential FDA leader.